1. Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: A randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial. (January 2015) Authors: Laties, Alan M; Flach, Allan J; Baldycheva, Irina; Rak, Ihor; Earley, Willie; Pathak, Sanjeev Journal: Journal of psychopharmacology Issue: Volume 29:Number 1(2015:Jan.) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗